학술논문
Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial
Document Type
Artikel
Author
Eikelboom, JW; Bosch, J; Connolly, SJ; Tyrwitt, J; Fox, KAA; Muehlhofer, E; Neumann, C; Tasto, C; Bangdiwala, S; Diaz, R; Alings, M; Dagenais, GR; Leong, DP; Lonn, EM; Avezum, A; Piegas, LS; Widimsky, P; Parkhomenko, AN; Bhatt, DL; Branch, KRH; Probstfield, JL; Lopez-Jaramillo, P; Ryden, L; Pogosova, N; Keltai, K; Keltai, M; Ertl, G; Stoerk, S; Dans, AL; Lanas, F; Liang, Y; Zhu, J; Torp-Pedersen, C; Maggioni, AP; Commerford, PJ; Guzik, TJ; Vanassche, T; Verhamme, P; O'Donnell, M; Tonkin, AM; Varigos, JD; Vinereanu, D; Felix, C; Kim, JH; Ibrahim, KS; Lewis, BS; Metsarinne, KP; Aboyans, V; Steg, PG; Hori, M; Kakkar, A; Anand, SS; Lamy, A; Sharma, M; Yusuf, S
Source
European heart journal. Cardiovascular pharmacotherapy. 8(8):786-795
Subject
Language
English
English
English
ISSN
2055-6845